Mexico: Government corruption leads to overpricing of up to 30% in public purchases, regulator claims
Mexico’s Federal Commission of Economic Competition (COFECE) has stated that federal government entities show signs of corruption among officials and suppliers, causing overpricing of up to 30% in public purchases. This is in addition to simulations of competition intended to benefit private companies, said COFECE president Alejandra Palacios.
Palacios pointed out that in 2017 the amount of resources involved in government procurement totalled $585 billion pesos (US$30 billion approximately)”.
[…] that would have been maximized with greater competition and translated into services and infrastructure of better quality.” She pointed out, however, that methods of circumventing state tender processes have been detected, using ambiguous or subjective justifications, while participation is restricted by means of unnecessary requirements.
COFECE’s president then presented a competition agenda for the full exercise of public procurement, which proposes, among other things: the issuance of a presidential decree that requires the participation of COFECE in relevant tenders, as well as recommendations for creating a virtual market and to force, through a decree, all entities within the Federal Public Administration to make small purchases through this system; to allow the participation of other bidders interested in the restricted procedures; and restrict the simultaneous participation of companies from the same Interest Group.
Full Content: Animal Político
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Regulator Puts Brakes on £762 Million Logistics Merger Amid Competition Fears
Nov 3, 2024 by
CPI
Nvidia’s Acquisition of AI Startup Run.ai Faces EU Antitrust Review
Nov 3, 2024 by
CPI
Voters Across US to Decide on Landmark Gig Economy Issues on November Ballots
Nov 3, 2024 by
CPI
Court Gives Green Light to $110M Deal in Real Estate Commission Dispute
Nov 3, 2024 by
CPI
Mexico’s First-Ever Class Action Targets Pharma Giants for Price Fixing
Nov 3, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI